Ligand validation:5BJU

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 5BJU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5BJU_NAD_A_702	92%	47%	0.096	0.985	0.75	1.3	2	5	1	0	100%	1
5BJU_NAD_B_702	91%	48%	0.095	0.981	0.8	1.18	-	5	0	0	100%	1
5BJY_NAD_B_702	97%	33%	0.068	0.985	0.81	1.8	1	11	2	0	100%	1
5BJX_NAD_A_702	96%	46%	0.074	0.984	0.78	1.28	1	5	2	0	100%	1
5BJW_NAD_A_702	95%	39%	0.073	0.979	0.96	1.42	1	10	2	0	100%	1
5BJV_NAD_A_701	94%	39%	0.085	0.986	0.7	1.64	1	12	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	16%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	7%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.